Ofatumumab Market, Global Outlook and Forecast 2022-2028
Ofatumumab is a fully human monoclonal antibody to CD20, which appears to inhibit early-stage B lymphocyte activation. Under the brand name Arzerra, it is approved for the treatment of certain types of chronic lymphocytic leukemia (CLL) in the United States. Under the brand name Kesimpta, it is approved for the treatment of multiple sclerosis in the United States as well as in the EU and other regions.
This report contains market size and forecasts of Ofatumumab in global, including the following market information:
Global Ofatumumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ofatumumab Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Ofatumumab companies in 2021 (%)
The global Ofatumumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ofatumumab include BOC Sciences, GlaxoSmithKline(GSK), Lonza Group, Novartis International, TargetMol Chemicals, Hubei Kele Fine Chemical, Jiangxi Ruiweier Biotechnology, Nantong Feiyu Biological Technology and Shanghai Biochempartner, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ofatumumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ofatumumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ofatumumab Market Segment Percentages, by Type, 2021 (%)
Global Ofatumumab Market Segment Percentages, by Application, 2021 (%)
Global Ofatumumab Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Ofatumumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ofatumumab revenues share in global market, 2021 (%)
Key companies Ofatumumab sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Ofatumumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Ofatumumab in global, including the following market information:
Global Ofatumumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ofatumumab Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Ofatumumab companies in 2021 (%)
The global Ofatumumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ofatumumab include BOC Sciences, GlaxoSmithKline(GSK), Lonza Group, Novartis International, TargetMol Chemicals, Hubei Kele Fine Chemical, Jiangxi Ruiweier Biotechnology, Nantong Feiyu Biological Technology and Shanghai Biochempartner, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ofatumumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ofatumumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ofatumumab Market Segment Percentages, by Type, 2021 (%)
- Patent
- Generic
Global Ofatumumab Market Segment Percentages, by Application, 2021 (%)
- Chemical
- Pharmaceutical
Global Ofatumumab Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Ofatumumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ofatumumab revenues share in global market, 2021 (%)
Key companies Ofatumumab sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Ofatumumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- BOC Sciences
- GlaxoSmithKline(GSK)
- Lonza Group
- Novartis International
- TargetMol Chemicals
- Hubei Kele Fine Chemical
- Jiangxi Ruiweier Biotechnology
- Nantong Feiyu Biological Technology
- Shanghai Biochempartner
- Shanghai Macklin Biochemical
- Shanghai Yifei Biotechnology
- Tianmen Hengchang Chemical
- Wuhan Topule Biopharmaceutical
- Wuhan Wogeda Biotechnology
- Wuhan Yingnuo Pharmaceutical Technology
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Ofatumumab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ofatumumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL OFATUMUMAB OVERALL MARKET SIZE
2.1 Global Ofatumumab Market Size: 2021 VS 2028
2.2 Global Ofatumumab Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Ofatumumab Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Ofatumumab Players in Global Market
3.2 Top Global Ofatumumab Companies Ranked by Revenue
3.3 Global Ofatumumab Revenue by Companies
3.4 Global Ofatumumab Sales by Companies
3.5 Global Ofatumumab Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Ofatumumab Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Ofatumumab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ofatumumab Players in Global Market
3.8.1 List of Global Tier 1 Ofatumumab Companies
3.8.2 List of Global Tier 2 and Tier 3 Ofatumumab Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Ofatumumab Market Size Markets, 2021 & 2028
4.1.2 Patent
4.1.3 Generic
4.2 By Type - Global Ofatumumab Revenue & Forecasts
4.2.1 By Type - Global Ofatumumab Revenue, 2017-2022
4.2.2 By Type - Global Ofatumumab Revenue, 2023-2028
4.2.3 By Type - Global Ofatumumab Revenue Market Share, 2017-2028
4.3 By Type - Global Ofatumumab Sales & Forecasts
4.3.1 By Type - Global Ofatumumab Sales, 2017-2022
4.3.2 By Type - Global Ofatumumab Sales, 2023-2028
4.3.3 By Type - Global Ofatumumab Sales Market Share, 2017-2028
4.4 By Type - Global Ofatumumab Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Ofatumumab Market Size, 2021 & 2028
5.1.2 Chemical
5.1.3 Pharmaceutical
5.2 By Application - Global Ofatumumab Revenue & Forecasts
5.2.1 By Application - Global Ofatumumab Revenue, 2017-2022
5.2.2 By Application - Global Ofatumumab Revenue, 2023-2028
5.2.3 By Application - Global Ofatumumab Revenue Market Share, 2017-2028
5.3 By Application - Global Ofatumumab Sales & Forecasts
5.3.1 By Application - Global Ofatumumab Sales, 2017-2022
5.3.2 By Application - Global Ofatumumab Sales, 2023-2028
5.3.3 By Application - Global Ofatumumab Sales Market Share, 2017-2028
5.4 By Application - Global Ofatumumab Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Ofatumumab Market Size, 2021 & 2028
6.2 By Region - Global Ofatumumab Revenue & Forecasts
6.2.1 By Region - Global Ofatumumab Revenue, 2017-2022
6.2.2 By Region - Global Ofatumumab Revenue, 2023-2028
6.2.3 By Region - Global Ofatumumab Revenue Market Share, 2017-2028
6.3 By Region - Global Ofatumumab Sales & Forecasts
6.3.1 By Region - Global Ofatumumab Sales, 2017-2022
6.3.2 By Region - Global Ofatumumab Sales, 2023-2028
6.3.3 By Region - Global Ofatumumab Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Ofatumumab Revenue, 2017-2028
6.4.2 By Country - North America Ofatumumab Sales, 2017-2028
6.4.3 US Ofatumumab Market Size, 2017-2028
6.4.4 Canada Ofatumumab Market Size, 2017-2028
6.4.5 Mexico Ofatumumab Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Ofatumumab Revenue, 2017-2028
6.5.2 By Country - Europe Ofatumumab Sales, 2017-2028
6.5.3 Germany Ofatumumab Market Size, 2017-2028
6.5.4 France Ofatumumab Market Size, 2017-2028
6.5.5 U.K. Ofatumumab Market Size, 2017-2028
6.5.6 Italy Ofatumumab Market Size, 2017-2028
6.5.7 Russia Ofatumumab Market Size, 2017-2028
6.5.8 Nordic Countries Ofatumumab Market Size, 2017-2028
6.5.9 Benelux Ofatumumab Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Ofatumumab Revenue, 2017-2028
6.6.2 By Region - Asia Ofatumumab Sales, 2017-2028
6.6.3 China Ofatumumab Market Size, 2017-2028
6.6.4 Japan Ofatumumab Market Size, 2017-2028
6.6.5 South Korea Ofatumumab Market Size, 2017-2028
6.6.6 Southeast Asia Ofatumumab Market Size, 2017-2028
6.6.7 India Ofatumumab Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Ofatumumab Revenue, 2017-2028
6.7.2 By Country - South America Ofatumumab Sales, 2017-2028
6.7.3 Brazil Ofatumumab Market Size, 2017-2028
6.7.4 Argentina Ofatumumab Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Ofatumumab Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Ofatumumab Sales, 2017-2028
6.8.3 Turkey Ofatumumab Market Size, 2017-2028
6.8.4 Israel Ofatumumab Market Size, 2017-2028
6.8.5 Saudi Arabia Ofatumumab Market Size, 2017-2028
6.8.6 UAE Ofatumumab Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 BOC Sciences
7.1.1 BOC Sciences Corporate Summary
7.1.2 BOC Sciences Business Overview
7.1.3 BOC Sciences Ofatumumab Major Product Offerings
7.1.4 BOC Sciences Ofatumumab Sales and Revenue in Global (2017-2022)
7.1.5 BOC Sciences Key News
7.2 GlaxoSmithKline(GSK)
7.2.1 GlaxoSmithKline(GSK) Corporate Summary
7.2.2 GlaxoSmithKline(GSK) Business Overview
7.2.3 GlaxoSmithKline(GSK) Ofatumumab Major Product Offerings
7.2.4 GlaxoSmithKline(GSK) Ofatumumab Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline(GSK) Key News
7.3 Lonza Group
7.3.1 Lonza Group Corporate Summary
7.3.2 Lonza Group Business Overview
7.3.3 Lonza Group Ofatumumab Major Product Offerings
7.3.4 Lonza Group Ofatumumab Sales and Revenue in Global (2017-2022)
7.3.5 Lonza Group Key News
7.4 Novartis International
7.4.1 Novartis International Corporate Summary
7.4.2 Novartis International Business Overview
7.4.3 Novartis International Ofatumumab Major Product Offerings
7.4.4 Novartis International Ofatumumab Sales and Revenue in Global (2017-2022)
7.4.5 Novartis International Key News
7.5 TargetMol Chemicals
7.5.1 TargetMol Chemicals Corporate Summary
7.5.2 TargetMol Chemicals Business Overview
7.5.3 TargetMol Chemicals Ofatumumab Major Product Offerings
7.5.4 TargetMol Chemicals Ofatumumab Sales and Revenue in Global (2017-2022)
7.5.5 TargetMol Chemicals Key News
7.6 Hubei Kele Fine Chemical
7.6.1 Hubei Kele Fine Chemical Corporate Summary
7.6.2 Hubei Kele Fine Chemical Business Overview
7.6.3 Hubei Kele Fine Chemical Ofatumumab Major Product Offerings
7.6.4 Hubei Kele Fine Chemical Ofatumumab Sales and Revenue in Global (2017-2022)
7.6.5 Hubei Kele Fine Chemical Key News
7.7 Jiangxi Ruiweier Biotechnology
7.7.1 Jiangxi Ruiweier Biotechnology Corporate Summary
7.7.2 Jiangxi Ruiweier Biotechnology Business Overview
7.7.3 Jiangxi Ruiweier Biotechnology Ofatumumab Major Product Offerings
7.7.4 Jiangxi Ruiweier Biotechnology Ofatumumab Sales and Revenue in Global (2017-2022)
7.7.5 Jiangxi Ruiweier Biotechnology Key News
7.8 Nantong Feiyu Biological Technology
7.8.1 Nantong Feiyu Biological Technology Corporate Summary
7.8.2 Nantong Feiyu Biological Technology Business Overview
7.8.3 Nantong Feiyu Biological Technology Ofatumumab Major Product Offerings
7.8.4 Nantong Feiyu Biological Technology Ofatumumab Sales and Revenue in Global (2017-2022)
7.8.5 Nantong Feiyu Biological Technology Key News
7.9 Shanghai Biochempartner
7.9.1 Shanghai Biochempartner Corporate Summary
7.9.2 Shanghai Biochempartner Business Overview
7.9.3 Shanghai Biochempartner Ofatumumab Major Product Offerings
7.9.4 Shanghai Biochempartner Ofatumumab Sales and Revenue in Global (2017-2022)
7.9.5 Shanghai Biochempartner Key News
7.10 Shanghai Macklin Biochemical
7.10.1 Shanghai Macklin Biochemical Corporate Summary
7.10.2 Shanghai Macklin Biochemical Business Overview
7.10.3 Shanghai Macklin Biochemical Ofatumumab Major Product Offerings
7.10.4 Shanghai Macklin Biochemical Ofatumumab Sales and Revenue in Global (2017-2022)
7.10.5 Shanghai Macklin Biochemical Key News
7.11 Shanghai Yifei Biotechnology
7.11.1 Shanghai Yifei Biotechnology Corporate Summary
7.11.2 Shanghai Yifei Biotechnology Ofatumumab Business Overview
7.11.3 Shanghai Yifei Biotechnology Ofatumumab Major Product Offerings
7.11.4 Shanghai Yifei Biotechnology Ofatumumab Sales and Revenue in Global (2017-2022)
7.11.5 Shanghai Yifei Biotechnology Key News
7.12 Tianmen Hengchang Chemical
7.12.1 Tianmen Hengchang Chemical Corporate Summary
7.12.2 Tianmen Hengchang Chemical Ofatumumab Business Overview
7.12.3 Tianmen Hengchang Chemical Ofatumumab Major Product Offerings
7.12.4 Tianmen Hengchang Chemical Ofatumumab Sales and Revenue in Global (2017-2022)
7.12.5 Tianmen Hengchang Chemical Key News
7.13 Wuhan Topule Biopharmaceutical
7.13.1 Wuhan Topule Biopharmaceutical Corporate Summary
7.13.2 Wuhan Topule Biopharmaceutical Ofatumumab Business Overview
7.13.3 Wuhan Topule Biopharmaceutical Ofatumumab Major Product Offerings
7.13.4 Wuhan Topule Biopharmaceutical Ofatumumab Sales and Revenue in Global (2017-2022)
7.13.5 Wuhan Topule Biopharmaceutical Key News
7.14 Wuhan Wogeda Biotechnology
7.14.1 Wuhan Wogeda Biotechnology Corporate Summary
7.14.2 Wuhan Wogeda Biotechnology Business Overview
7.14.3 Wuhan Wogeda Biotechnology Ofatumumab Major Product Offerings
7.14.4 Wuhan Wogeda Biotechnology Ofatumumab Sales and Revenue in Global (2017-2022)
7.14.5 Wuhan Wogeda Biotechnology Key News
7.15 Wuhan Yingnuo Pharmaceutical Technology
7.15.1 Wuhan Yingnuo Pharmaceutical Technology Corporate Summary
7.15.2 Wuhan Yingnuo Pharmaceutical Technology Business Overview
7.15.3 Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Major Product Offerings
7.15.4 Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Sales and Revenue in Global (2017-2022)
7.15.5 Wuhan Yingnuo Pharmaceutical Technology Key News
8 GLOBAL OFATUMUMAB PRODUCTION CAPACITY, ANALYSIS
8.1 Global Ofatumumab Production Capacity, 2017-2028
8.2 Ofatumumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Ofatumumab Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 OFATUMUMAB SUPPLY CHAIN ANALYSIS
10.1 Ofatumumab Industry Value Chain
10.2 Ofatumumab Upstream Market
10.3 Ofatumumab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ofatumumab Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Ofatumumab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ofatumumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL OFATUMUMAB OVERALL MARKET SIZE
2.1 Global Ofatumumab Market Size: 2021 VS 2028
2.2 Global Ofatumumab Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Ofatumumab Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Ofatumumab Players in Global Market
3.2 Top Global Ofatumumab Companies Ranked by Revenue
3.3 Global Ofatumumab Revenue by Companies
3.4 Global Ofatumumab Sales by Companies
3.5 Global Ofatumumab Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Ofatumumab Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Ofatumumab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ofatumumab Players in Global Market
3.8.1 List of Global Tier 1 Ofatumumab Companies
3.8.2 List of Global Tier 2 and Tier 3 Ofatumumab Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Ofatumumab Market Size Markets, 2021 & 2028
4.1.2 Patent
4.1.3 Generic
4.2 By Type - Global Ofatumumab Revenue & Forecasts
4.2.1 By Type - Global Ofatumumab Revenue, 2017-2022
4.2.2 By Type - Global Ofatumumab Revenue, 2023-2028
4.2.3 By Type - Global Ofatumumab Revenue Market Share, 2017-2028
4.3 By Type - Global Ofatumumab Sales & Forecasts
4.3.1 By Type - Global Ofatumumab Sales, 2017-2022
4.3.2 By Type - Global Ofatumumab Sales, 2023-2028
4.3.3 By Type - Global Ofatumumab Sales Market Share, 2017-2028
4.4 By Type - Global Ofatumumab Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Ofatumumab Market Size, 2021 & 2028
5.1.2 Chemical
5.1.3 Pharmaceutical
5.2 By Application - Global Ofatumumab Revenue & Forecasts
5.2.1 By Application - Global Ofatumumab Revenue, 2017-2022
5.2.2 By Application - Global Ofatumumab Revenue, 2023-2028
5.2.3 By Application - Global Ofatumumab Revenue Market Share, 2017-2028
5.3 By Application - Global Ofatumumab Sales & Forecasts
5.3.1 By Application - Global Ofatumumab Sales, 2017-2022
5.3.2 By Application - Global Ofatumumab Sales, 2023-2028
5.3.3 By Application - Global Ofatumumab Sales Market Share, 2017-2028
5.4 By Application - Global Ofatumumab Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Ofatumumab Market Size, 2021 & 2028
6.2 By Region - Global Ofatumumab Revenue & Forecasts
6.2.1 By Region - Global Ofatumumab Revenue, 2017-2022
6.2.2 By Region - Global Ofatumumab Revenue, 2023-2028
6.2.3 By Region - Global Ofatumumab Revenue Market Share, 2017-2028
6.3 By Region - Global Ofatumumab Sales & Forecasts
6.3.1 By Region - Global Ofatumumab Sales, 2017-2022
6.3.2 By Region - Global Ofatumumab Sales, 2023-2028
6.3.3 By Region - Global Ofatumumab Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Ofatumumab Revenue, 2017-2028
6.4.2 By Country - North America Ofatumumab Sales, 2017-2028
6.4.3 US Ofatumumab Market Size, 2017-2028
6.4.4 Canada Ofatumumab Market Size, 2017-2028
6.4.5 Mexico Ofatumumab Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Ofatumumab Revenue, 2017-2028
6.5.2 By Country - Europe Ofatumumab Sales, 2017-2028
6.5.3 Germany Ofatumumab Market Size, 2017-2028
6.5.4 France Ofatumumab Market Size, 2017-2028
6.5.5 U.K. Ofatumumab Market Size, 2017-2028
6.5.6 Italy Ofatumumab Market Size, 2017-2028
6.5.7 Russia Ofatumumab Market Size, 2017-2028
6.5.8 Nordic Countries Ofatumumab Market Size, 2017-2028
6.5.9 Benelux Ofatumumab Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Ofatumumab Revenue, 2017-2028
6.6.2 By Region - Asia Ofatumumab Sales, 2017-2028
6.6.3 China Ofatumumab Market Size, 2017-2028
6.6.4 Japan Ofatumumab Market Size, 2017-2028
6.6.5 South Korea Ofatumumab Market Size, 2017-2028
6.6.6 Southeast Asia Ofatumumab Market Size, 2017-2028
6.6.7 India Ofatumumab Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Ofatumumab Revenue, 2017-2028
6.7.2 By Country - South America Ofatumumab Sales, 2017-2028
6.7.3 Brazil Ofatumumab Market Size, 2017-2028
6.7.4 Argentina Ofatumumab Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Ofatumumab Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Ofatumumab Sales, 2017-2028
6.8.3 Turkey Ofatumumab Market Size, 2017-2028
6.8.4 Israel Ofatumumab Market Size, 2017-2028
6.8.5 Saudi Arabia Ofatumumab Market Size, 2017-2028
6.8.6 UAE Ofatumumab Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 BOC Sciences
7.1.1 BOC Sciences Corporate Summary
7.1.2 BOC Sciences Business Overview
7.1.3 BOC Sciences Ofatumumab Major Product Offerings
7.1.4 BOC Sciences Ofatumumab Sales and Revenue in Global (2017-2022)
7.1.5 BOC Sciences Key News
7.2 GlaxoSmithKline(GSK)
7.2.1 GlaxoSmithKline(GSK) Corporate Summary
7.2.2 GlaxoSmithKline(GSK) Business Overview
7.2.3 GlaxoSmithKline(GSK) Ofatumumab Major Product Offerings
7.2.4 GlaxoSmithKline(GSK) Ofatumumab Sales and Revenue in Global (2017-2022)
7.2.5 GlaxoSmithKline(GSK) Key News
7.3 Lonza Group
7.3.1 Lonza Group Corporate Summary
7.3.2 Lonza Group Business Overview
7.3.3 Lonza Group Ofatumumab Major Product Offerings
7.3.4 Lonza Group Ofatumumab Sales and Revenue in Global (2017-2022)
7.3.5 Lonza Group Key News
7.4 Novartis International
7.4.1 Novartis International Corporate Summary
7.4.2 Novartis International Business Overview
7.4.3 Novartis International Ofatumumab Major Product Offerings
7.4.4 Novartis International Ofatumumab Sales and Revenue in Global (2017-2022)
7.4.5 Novartis International Key News
7.5 TargetMol Chemicals
7.5.1 TargetMol Chemicals Corporate Summary
7.5.2 TargetMol Chemicals Business Overview
7.5.3 TargetMol Chemicals Ofatumumab Major Product Offerings
7.5.4 TargetMol Chemicals Ofatumumab Sales and Revenue in Global (2017-2022)
7.5.5 TargetMol Chemicals Key News
7.6 Hubei Kele Fine Chemical
7.6.1 Hubei Kele Fine Chemical Corporate Summary
7.6.2 Hubei Kele Fine Chemical Business Overview
7.6.3 Hubei Kele Fine Chemical Ofatumumab Major Product Offerings
7.6.4 Hubei Kele Fine Chemical Ofatumumab Sales and Revenue in Global (2017-2022)
7.6.5 Hubei Kele Fine Chemical Key News
7.7 Jiangxi Ruiweier Biotechnology
7.7.1 Jiangxi Ruiweier Biotechnology Corporate Summary
7.7.2 Jiangxi Ruiweier Biotechnology Business Overview
7.7.3 Jiangxi Ruiweier Biotechnology Ofatumumab Major Product Offerings
7.7.4 Jiangxi Ruiweier Biotechnology Ofatumumab Sales and Revenue in Global (2017-2022)
7.7.5 Jiangxi Ruiweier Biotechnology Key News
7.8 Nantong Feiyu Biological Technology
7.8.1 Nantong Feiyu Biological Technology Corporate Summary
7.8.2 Nantong Feiyu Biological Technology Business Overview
7.8.3 Nantong Feiyu Biological Technology Ofatumumab Major Product Offerings
7.8.4 Nantong Feiyu Biological Technology Ofatumumab Sales and Revenue in Global (2017-2022)
7.8.5 Nantong Feiyu Biological Technology Key News
7.9 Shanghai Biochempartner
7.9.1 Shanghai Biochempartner Corporate Summary
7.9.2 Shanghai Biochempartner Business Overview
7.9.3 Shanghai Biochempartner Ofatumumab Major Product Offerings
7.9.4 Shanghai Biochempartner Ofatumumab Sales and Revenue in Global (2017-2022)
7.9.5 Shanghai Biochempartner Key News
7.10 Shanghai Macklin Biochemical
7.10.1 Shanghai Macklin Biochemical Corporate Summary
7.10.2 Shanghai Macklin Biochemical Business Overview
7.10.3 Shanghai Macklin Biochemical Ofatumumab Major Product Offerings
7.10.4 Shanghai Macklin Biochemical Ofatumumab Sales and Revenue in Global (2017-2022)
7.10.5 Shanghai Macklin Biochemical Key News
7.11 Shanghai Yifei Biotechnology
7.11.1 Shanghai Yifei Biotechnology Corporate Summary
7.11.2 Shanghai Yifei Biotechnology Ofatumumab Business Overview
7.11.3 Shanghai Yifei Biotechnology Ofatumumab Major Product Offerings
7.11.4 Shanghai Yifei Biotechnology Ofatumumab Sales and Revenue in Global (2017-2022)
7.11.5 Shanghai Yifei Biotechnology Key News
7.12 Tianmen Hengchang Chemical
7.12.1 Tianmen Hengchang Chemical Corporate Summary
7.12.2 Tianmen Hengchang Chemical Ofatumumab Business Overview
7.12.3 Tianmen Hengchang Chemical Ofatumumab Major Product Offerings
7.12.4 Tianmen Hengchang Chemical Ofatumumab Sales and Revenue in Global (2017-2022)
7.12.5 Tianmen Hengchang Chemical Key News
7.13 Wuhan Topule Biopharmaceutical
7.13.1 Wuhan Topule Biopharmaceutical Corporate Summary
7.13.2 Wuhan Topule Biopharmaceutical Ofatumumab Business Overview
7.13.3 Wuhan Topule Biopharmaceutical Ofatumumab Major Product Offerings
7.13.4 Wuhan Topule Biopharmaceutical Ofatumumab Sales and Revenue in Global (2017-2022)
7.13.5 Wuhan Topule Biopharmaceutical Key News
7.14 Wuhan Wogeda Biotechnology
7.14.1 Wuhan Wogeda Biotechnology Corporate Summary
7.14.2 Wuhan Wogeda Biotechnology Business Overview
7.14.3 Wuhan Wogeda Biotechnology Ofatumumab Major Product Offerings
7.14.4 Wuhan Wogeda Biotechnology Ofatumumab Sales and Revenue in Global (2017-2022)
7.14.5 Wuhan Wogeda Biotechnology Key News
7.15 Wuhan Yingnuo Pharmaceutical Technology
7.15.1 Wuhan Yingnuo Pharmaceutical Technology Corporate Summary
7.15.2 Wuhan Yingnuo Pharmaceutical Technology Business Overview
7.15.3 Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Major Product Offerings
7.15.4 Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Sales and Revenue in Global (2017-2022)
7.15.5 Wuhan Yingnuo Pharmaceutical Technology Key News
8 GLOBAL OFATUMUMAB PRODUCTION CAPACITY, ANALYSIS
8.1 Global Ofatumumab Production Capacity, 2017-2028
8.2 Ofatumumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Ofatumumab Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 OFATUMUMAB SUPPLY CHAIN ANALYSIS
10.1 Ofatumumab Industry Value Chain
10.2 Ofatumumab Upstream Market
10.3 Ofatumumab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ofatumumab Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Ofatumumab in Global Market
Table 2. Top Ofatumumab Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Ofatumumab Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Ofatumumab Revenue Share by Companies, 2017-2022
Table 5. Global Ofatumumab Sales by Companies, (Kg), 2017-2022
Table 6. Global Ofatumumab Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Ofatumumab Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Ofatumumab Product Type
Table 9. List of Global Tier 1 Ofatumumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ofatumumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ofatumumab Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Ofatumumab Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Ofatumumab Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Ofatumumab Sales (Kg), 2017-2022
Table 15. By Type - Global Ofatumumab Sales (Kg), 2023-2028
Table 16. By Application – Global Ofatumumab Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Ofatumumab Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Ofatumumab Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Ofatumumab Sales (Kg), 2017-2022
Table 20. By Application - Global Ofatumumab Sales (Kg), 2023-2028
Table 21. By Region – Global Ofatumumab Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Ofatumumab Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Ofatumumab Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Ofatumumab Sales (Kg), 2017-2022
Table 25. By Region - Global Ofatumumab Sales (Kg), 2023-2028
Table 26. By Country - North America Ofatumumab Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Ofatumumab Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Ofatumumab Sales, (Kg), 2017-2022
Table 29. By Country - North America Ofatumumab Sales, (Kg), 2023-2028
Table 30. By Country - Europe Ofatumumab Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Ofatumumab Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Ofatumumab Sales, (Kg), 2017-2022
Table 33. By Country - Europe Ofatumumab Sales, (Kg), 2023-2028
Table 34. By Region - Asia Ofatumumab Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Ofatumumab Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Ofatumumab Sales, (Kg), 2017-2022
Table 37. By Region - Asia Ofatumumab Sales, (Kg), 2023-2028
Table 38. By Country - South America Ofatumumab Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Ofatumumab Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Ofatumumab Sales, (Kg), 2017-2022
Table 41. By Country - South America Ofatumumab Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Ofatumumab Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Ofatumumab Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Ofatumumab Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Ofatumumab Sales, (Kg), 2023-2028
Table 46. BOC Sciences Corporate Summary
Table 47. BOC Sciences Ofatumumab Product Offerings
Table 48. BOC Sciences Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. GlaxoSmithKline(GSK) Corporate Summary
Table 50. GlaxoSmithKline(GSK) Ofatumumab Product Offerings
Table 51. GlaxoSmithKline(GSK) Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. Lonza Group Corporate Summary
Table 53. Lonza Group Ofatumumab Product Offerings
Table 54. Lonza Group Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. Novartis International Corporate Summary
Table 56. Novartis International Ofatumumab Product Offerings
Table 57. Novartis International Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. TargetMol Chemicals Corporate Summary
Table 59. TargetMol Chemicals Ofatumumab Product Offerings
Table 60. TargetMol Chemicals Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Hubei Kele Fine Chemical Corporate Summary
Table 62. Hubei Kele Fine Chemical Ofatumumab Product Offerings
Table 63. Hubei Kele Fine Chemical Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. Jiangxi Ruiweier Biotechnology Corporate Summary
Table 65. Jiangxi Ruiweier Biotechnology Ofatumumab Product Offerings
Table 66. Jiangxi Ruiweier Biotechnology Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Nantong Feiyu Biological Technology Corporate Summary
Table 68. Nantong Feiyu Biological Technology Ofatumumab Product Offerings
Table 69. Nantong Feiyu Biological Technology Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Shanghai Biochempartner Corporate Summary
Table 71. Shanghai Biochempartner Ofatumumab Product Offerings
Table 72. Shanghai Biochempartner Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Shanghai Macklin Biochemical Corporate Summary
Table 74. Shanghai Macklin Biochemical Ofatumumab Product Offerings
Table 75. Shanghai Macklin Biochemical Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 76. Shanghai Yifei Biotechnology Corporate Summary
Table 77. Shanghai Yifei Biotechnology Ofatumumab Product Offerings
Table 78. Shanghai Yifei Biotechnology Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 79. Tianmen Hengchang Chemical Corporate Summary
Table 80. Tianmen Hengchang Chemical Ofatumumab Product Offerings
Table 81. Tianmen Hengchang Chemical Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 82. Wuhan Topule Biopharmaceutical Corporate Summary
Table 83. Wuhan Topule Biopharmaceutical Ofatumumab Product Offerings
Table 84. Wuhan Topule Biopharmaceutical Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 85. Wuhan Wogeda Biotechnology Corporate Summary
Table 86. Wuhan Wogeda Biotechnology Ofatumumab Product Offerings
Table 87. Wuhan Wogeda Biotechnology Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 88. Wuhan Yingnuo Pharmaceutical Technology Corporate Summary
Table 89. Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Product Offerings
Table 90. Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 91. Ofatumumab Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 92. Global Ofatumumab Capacity Market Share of Key Manufacturers, 2020-2022
Table 93. Global Ofatumumab Production by Region, 2017-2022 (Kg)
Table 94. Global Ofatumumab Production by Region, 2023-2028 (Kg)
Table 95. Ofatumumab Market Opportunities & Trends in Global Market
Table 96. Ofatumumab Market Drivers in Global Market
Table 97. Ofatumumab Market Restraints in Global Market
Table 98. Ofatumumab Raw Materials
Table 99. Ofatumumab Raw Materials Suppliers in Global Market
Table 100. Typical Ofatumumab Downstream
Table 101. Ofatumumab Downstream Clients in Global Market
Table 102. Ofatumumab Distributors and Sales Agents in Global Market
Table 1. Key Players of Ofatumumab in Global Market
Table 2. Top Ofatumumab Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Ofatumumab Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Ofatumumab Revenue Share by Companies, 2017-2022
Table 5. Global Ofatumumab Sales by Companies, (Kg), 2017-2022
Table 6. Global Ofatumumab Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Ofatumumab Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Ofatumumab Product Type
Table 9. List of Global Tier 1 Ofatumumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ofatumumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ofatumumab Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Ofatumumab Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Ofatumumab Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Ofatumumab Sales (Kg), 2017-2022
Table 15. By Type - Global Ofatumumab Sales (Kg), 2023-2028
Table 16. By Application – Global Ofatumumab Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Ofatumumab Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Ofatumumab Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Ofatumumab Sales (Kg), 2017-2022
Table 20. By Application - Global Ofatumumab Sales (Kg), 2023-2028
Table 21. By Region – Global Ofatumumab Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Ofatumumab Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Ofatumumab Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Ofatumumab Sales (Kg), 2017-2022
Table 25. By Region - Global Ofatumumab Sales (Kg), 2023-2028
Table 26. By Country - North America Ofatumumab Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Ofatumumab Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Ofatumumab Sales, (Kg), 2017-2022
Table 29. By Country - North America Ofatumumab Sales, (Kg), 2023-2028
Table 30. By Country - Europe Ofatumumab Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Ofatumumab Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Ofatumumab Sales, (Kg), 2017-2022
Table 33. By Country - Europe Ofatumumab Sales, (Kg), 2023-2028
Table 34. By Region - Asia Ofatumumab Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Ofatumumab Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Ofatumumab Sales, (Kg), 2017-2022
Table 37. By Region - Asia Ofatumumab Sales, (Kg), 2023-2028
Table 38. By Country - South America Ofatumumab Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Ofatumumab Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Ofatumumab Sales, (Kg), 2017-2022
Table 41. By Country - South America Ofatumumab Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Ofatumumab Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Ofatumumab Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Ofatumumab Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Ofatumumab Sales, (Kg), 2023-2028
Table 46. BOC Sciences Corporate Summary
Table 47. BOC Sciences Ofatumumab Product Offerings
Table 48. BOC Sciences Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. GlaxoSmithKline(GSK) Corporate Summary
Table 50. GlaxoSmithKline(GSK) Ofatumumab Product Offerings
Table 51. GlaxoSmithKline(GSK) Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. Lonza Group Corporate Summary
Table 53. Lonza Group Ofatumumab Product Offerings
Table 54. Lonza Group Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. Novartis International Corporate Summary
Table 56. Novartis International Ofatumumab Product Offerings
Table 57. Novartis International Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. TargetMol Chemicals Corporate Summary
Table 59. TargetMol Chemicals Ofatumumab Product Offerings
Table 60. TargetMol Chemicals Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Hubei Kele Fine Chemical Corporate Summary
Table 62. Hubei Kele Fine Chemical Ofatumumab Product Offerings
Table 63. Hubei Kele Fine Chemical Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. Jiangxi Ruiweier Biotechnology Corporate Summary
Table 65. Jiangxi Ruiweier Biotechnology Ofatumumab Product Offerings
Table 66. Jiangxi Ruiweier Biotechnology Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Nantong Feiyu Biological Technology Corporate Summary
Table 68. Nantong Feiyu Biological Technology Ofatumumab Product Offerings
Table 69. Nantong Feiyu Biological Technology Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Shanghai Biochempartner Corporate Summary
Table 71. Shanghai Biochempartner Ofatumumab Product Offerings
Table 72. Shanghai Biochempartner Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Shanghai Macklin Biochemical Corporate Summary
Table 74. Shanghai Macklin Biochemical Ofatumumab Product Offerings
Table 75. Shanghai Macklin Biochemical Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 76. Shanghai Yifei Biotechnology Corporate Summary
Table 77. Shanghai Yifei Biotechnology Ofatumumab Product Offerings
Table 78. Shanghai Yifei Biotechnology Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 79. Tianmen Hengchang Chemical Corporate Summary
Table 80. Tianmen Hengchang Chemical Ofatumumab Product Offerings
Table 81. Tianmen Hengchang Chemical Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 82. Wuhan Topule Biopharmaceutical Corporate Summary
Table 83. Wuhan Topule Biopharmaceutical Ofatumumab Product Offerings
Table 84. Wuhan Topule Biopharmaceutical Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 85. Wuhan Wogeda Biotechnology Corporate Summary
Table 86. Wuhan Wogeda Biotechnology Ofatumumab Product Offerings
Table 87. Wuhan Wogeda Biotechnology Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 88. Wuhan Yingnuo Pharmaceutical Technology Corporate Summary
Table 89. Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Product Offerings
Table 90. Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 91. Ofatumumab Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 92. Global Ofatumumab Capacity Market Share of Key Manufacturers, 2020-2022
Table 93. Global Ofatumumab Production by Region, 2017-2022 (Kg)
Table 94. Global Ofatumumab Production by Region, 2023-2028 (Kg)
Table 95. Ofatumumab Market Opportunities & Trends in Global Market
Table 96. Ofatumumab Market Drivers in Global Market
Table 97. Ofatumumab Market Restraints in Global Market
Table 98. Ofatumumab Raw Materials
Table 99. Ofatumumab Raw Materials Suppliers in Global Market
Table 100. Typical Ofatumumab Downstream
Table 101. Ofatumumab Downstream Clients in Global Market
Table 102. Ofatumumab Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Ofatumumab Segment by Type
Figure 2. Ofatumumab Segment by Application
Figure 3. Global Ofatumumab Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ofatumumab Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ofatumumab Revenue, 2017-2028 (US$, Mn)
Figure 7. Ofatumumab Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Ofatumumab Revenue in 2021
Figure 9. By Type - Global Ofatumumab Sales Market Share, 2017-2028
Figure 10. By Type - Global Ofatumumab Revenue Market Share, 2017-2028
Figure 11. By Type - Global Ofatumumab Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Ofatumumab Sales Market Share, 2017-2028
Figure 13. By Application - Global Ofatumumab Revenue Market Share, 2017-2028
Figure 14. By Application - Global Ofatumumab Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Ofatumumab Sales Market Share, 2017-2028
Figure 16. By Region - Global Ofatumumab Revenue Market Share, 2017-2028
Figure 17. By Country - North America Ofatumumab Revenue Market Share, 2017-2028
Figure 18. By Country - North America Ofatumumab Sales Market Share, 2017-2028
Figure 19. US Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Ofatumumab Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Ofatumumab Sales Market Share, 2017-2028
Figure 24. Germany Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 25. France Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Ofatumumab Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Ofatumumab Sales Market Share, 2017-2028
Figure 33. China Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 37. India Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Ofatumumab Revenue Market Share, 2017-2028
Figure 39. By Country - South America Ofatumumab Sales Market Share, 2017-2028
Figure 40. Brazil Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Ofatumumab Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Ofatumumab Sales Market Share, 2017-2028
Figure 44. Turkey Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 48. Global Ofatumumab Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Ofatumumab by Region, 2021 VS 2028
Figure 50. Ofatumumab Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Ofatumumab Segment by Type
Figure 2. Ofatumumab Segment by Application
Figure 3. Global Ofatumumab Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ofatumumab Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ofatumumab Revenue, 2017-2028 (US$, Mn)
Figure 7. Ofatumumab Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Ofatumumab Revenue in 2021
Figure 9. By Type - Global Ofatumumab Sales Market Share, 2017-2028
Figure 10. By Type - Global Ofatumumab Revenue Market Share, 2017-2028
Figure 11. By Type - Global Ofatumumab Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Ofatumumab Sales Market Share, 2017-2028
Figure 13. By Application - Global Ofatumumab Revenue Market Share, 2017-2028
Figure 14. By Application - Global Ofatumumab Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Ofatumumab Sales Market Share, 2017-2028
Figure 16. By Region - Global Ofatumumab Revenue Market Share, 2017-2028
Figure 17. By Country - North America Ofatumumab Revenue Market Share, 2017-2028
Figure 18. By Country - North America Ofatumumab Sales Market Share, 2017-2028
Figure 19. US Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Ofatumumab Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Ofatumumab Sales Market Share, 2017-2028
Figure 24. Germany Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 25. France Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Ofatumumab Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Ofatumumab Sales Market Share, 2017-2028
Figure 33. China Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 37. India Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Ofatumumab Revenue Market Share, 2017-2028
Figure 39. By Country - South America Ofatumumab Sales Market Share, 2017-2028
Figure 40. Brazil Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Ofatumumab Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Ofatumumab Sales Market Share, 2017-2028
Figure 44. Turkey Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Ofatumumab Revenue, (US$, Mn), 2017-2028
Figure 48. Global Ofatumumab Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Ofatumumab by Region, 2021 VS 2028
Figure 50. Ofatumumab Industry Value Chain
Figure 51. Marketing Channels
